
Loading, please wait...

Loading, please wait...

Recent advancements in oncology highlight the importance of the mitotic motor protein Kinesin Family Member 11 (KIF11). Specifically, the search for novel KIF11 inhibitors in EC (Endometrial Carcinoma) has gained momentum due to the protein's significant overexpression. A study published in OMICS (2026) utilized an integrated computational framework to identify natural product inhibitors. By combining transcriptomic and proteomic data from global datasets, researchers successfully validated KIF11 as a critical driver of malignancy in endometrial cancer.
Endometrial carcinoma presents a growing health challenge in India, often characterized by significant molecular heterogeneity. Consequently, targeting specific motor proteins like KIF11 offers a strategic pathway toward precision therapeutics. In this study, researchers performed a pharmacophore-based virtual screening of approximately 400,000 natural compounds. Although glycodeoxycholic acid (GDCA) initially showed the highest docking affinity, molecular dynamics simulations identified glycocholic acid (GCA) as the superior candidate. Furthermore, GCA exhibited remarkable conformational stability and maintained persistent hydrogen bonds with essential residues like LYS111 and GLU118.
The integration of structural biology with multiomics allows for faster and more accurate identification of lead candidates. This study underscores the efficacy of using natural product-based inhibitors to drive oncological drug discovery. Moreover, the stable profile of GCA provides a promising foundation for future clinical validation. Physicians should stay informed about these emerging precision medicine strategies as they may soon influence standard care protocols. Finally, this approach highlights how bioinformatics can bridge the gap between genomic data and clinical application.
KIF11 is a motor protein essential for spindle assembly during cell division. Its upregulation is strongly linked to aggressive tumor progression and poor survival rates in patients with endometrial carcinoma.
While many compounds show initial binding potential, GCA demonstrated superior conformational stability during 100 ns simulations. It maintained a stable RMSD profile and consistent molecular interactions, unlike other screened compounds.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
Sarwat S et al. Integrated Computational Omics Approach to Identify Novel Natural Product Inhibitors Targeting KIF11 in Endometrial Carcinoma. OMICS. 2026 May 04. doi: 10.1177/15578100261446772. PMID: 42081267.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Study identifies Glycocholic acid as a stable KIF11 inhibitor for Endometrial Carcinoma, offering a novel precision medicine approach via multiomics....
4 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today